GEP20197053B - Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof - Google Patents

Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof

Info

Publication number
GEP20197053B
GEP20197053B GEAP201414100A GEAP2014014100A GEP20197053B GE P20197053 B GEP20197053 B GE P20197053B GE AP201414100 A GEAP201414100 A GE AP201414100A GE AP2014014100 A GEAP2014014100 A GE AP2014014100A GE P20197053 B GEP20197053 B GE P20197053B
Authority
GE
Georgia
Prior art keywords
binding
specific monovalent
monovalent diabodies
uses therof
therof
Prior art date
Application number
GEAP201414100A
Other languages
English (en)
Inventor
Inc Macrogenics
Original Assignee
Inc Macrogenics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65632998&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP20197053(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP13198784.4A external-priority patent/EP2839842A1/en
Application filed by Inc Macrogenics filed Critical Inc Macrogenics
Publication of GEP20197053B publication Critical patent/GEP20197053B/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GEAP201414100A 2013-08-23 2014-08-20 Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof GEP20197053B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361869510P 2013-08-23 2013-08-23
US201361907749P 2013-11-22 2013-11-22
EP13198784.4A EP2839842A1 (en) 2013-08-23 2013-12-20 Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
US201461990475P 2014-05-08 2014-05-08

Publications (1)

Publication Number Publication Date
GEP20197053B true GEP20197053B (en) 2019-12-25

Family

ID=65632998

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201414100A GEP20197053B (en) 2013-08-23 2014-08-20 Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof

Country Status (9)

Country Link
CL (1) CL2016000362A1 (es)
DK (1) DK3035965T3 (es)
ES (1) ES2860973T3 (es)
GE (1) GEP20197053B (es)
HK (1) HK1225999A1 (es)
HR (1) HRP20210215T1 (es)
HU (1) HUE054315T2 (es)
LT (1) LT3035965T (es)
UA (1) UA119539C2 (es)

Also Published As

Publication number Publication date
HK1225999A1 (zh) 2017-09-22
ES2860973T3 (es) 2021-10-05
CL2016000362A1 (es) 2016-10-28
LT3035965T (lt) 2021-04-12
HUE054315T2 (hu) 2021-08-30
HRP20210215T1 (hr) 2021-04-16
DK3035965T3 (da) 2021-02-15
UA119539C2 (uk) 2019-07-10
NZ716914A (en) 2021-09-24

Similar Documents

Publication Publication Date Title
PH12016500311A1 (en) Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses thereof
PH12017500544A1 (en) Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereof
PH12017502019A1 (en) Heterodimeric antibodies that bind cd3 and tumor antigens
MX2021003704A (es) Anticuerpos heterodimericos que se unen a cd3 y a antigenos tumorales.
PH12018500363A1 (en) Bispecific monovalent diabodies that are capable of binding b7-h3 and cd3, and uses thereof
PH12017500982A1 (en) Heterodimeric antibodies that bind cd3 and cd38
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
GEP20197033B (en) Bi-specific monovalent diabodies that are capable of binding to gpa33 and cd3, and uses thereof
PH12016501908A1 (en) Bispecific antibodies that bind to cd38 and cd3
MX2018010295A (es) Anticuerpos que tienen especificidad para atenuador de linfocitos b y t (btla) y usos de los mismos.
MX2016009050A (es) Construcciones biespecificas de union a los antigenos cd3 y cd19.
GEP20197053B (en) Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof